Tesaro Company Profile (NASDAQ:TSRO)

About Tesaro

Tesaro logoTESARO, Inc. is an oncology-focused biopharmaceutical company. The Company acquires, in-licenses and develops oncology product candidates. It operates in business of developing and commercializing oncology-focused therapeutics segment. It has in-licensed and are developing oncology-related product candidates, including intravenous (IV) rolapitant and niraparib, as well as product candidates under its immuno-oncology platform. It offers VARUBI (rolapitant), which is an oral substance P/neurokinin 1 (NK-1) receptor antagonist for use in combination with other antiemetic agents in adults for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy. It is developing IV formulation of rolapitant, which has completed various Phase 1 clinical trials. Its niraparib is an orally active and poly (ADP-ribose) polymerase (PARP) inhibitor. Its immuno-oncology platform has immuno-oncology programs, which include TSR-022 and TSR-042.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: TSRO
  • CUSIP: 88156910
Key Metrics:
  • Previous Close: $117.80
  • 50 Day Moving Average: $103.85
  • 200 Day Moving Average: $73.69
  • 52-Week Range: $29.51 - $122.89
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -19.28
  • P/E Growth: -0.64
  • Market Cap: $6.05B
  • Outstanding Shares: 51,365,000
  • Beta: 1.62
  • Net Margins: -783.97%
  • Return on Equity: -205.63%
  • Return on Assets: -91.81%
  • Debt-to-Equity Ratio: 0.75%
  • Current Ratio: 5.63%
  • Quick Ratio: 5.49%
Additional Links:
Companies Related to Tesaro:

Analyst Ratings

Consensus Ratings for Tesaro (NASDAQ:TSRO) (?)
Ratings Breakdown: 1 Hold Rating, 13 Buy Ratings
Consensus Rating:Buy (Score: 2.93)
Consensus Price Target: $114.97 (2.40% downside)

Analysts' Ratings History for Tesaro (NASDAQ:TSRO)
DateFirmActionRatingPrice TargetDetails
10/12/2016Citigroup Inc.Reiterated RatingBuy$120.00 -> $125.00View Rating Details
10/10/2016Credit Suisse Group AGReiterated RatingOutperform$90.00 -> $122.00View Rating Details
10/10/2016Leerink SwannReiterated RatingOutperform$108.00 -> $115.00View Rating Details
10/10/2016Robert W. BairdBoost Price TargetOutperform$105.00 -> $120.00View Rating Details
10/10/2016RBC Capital MarketsBoost Price TargetOutperform$122.00 -> $128.00View Rating Details
10/10/2016WedbushBoost Price TargetOutperform$107.00 -> $139.00View Rating Details
10/10/2016Royal Bank Of CanadaBoost Price TargetOutperform$122.00 -> $128.00View Rating Details
10/10/2016Bank of America Corp.UpgradeNeutral -> Buy$123.00View Rating Details
10/10/2016FBR & CoBoost Price TargetOutperform$102.00 -> $115.00View Rating Details
9/14/2016SunTrust Banks Inc.Reiterated RatingBuy$91.60View Rating Details
9/6/2016Lake Street CapitalReiterated RatingBuy$114.00View Rating Details
8/5/2016Jefferies GroupSet Price TargetHold$75.00 -> $80.00View Rating Details
8/5/2016MizuhoLower Price TargetBuy$100.00 -> $94.00View Rating Details
6/30/2016Wells Fargo & Co.Reiterated RatingOutperformView Rating Details
8/31/2015Raymond James Financial Inc.Initiated CoverageStrong-Buy$70.00View Rating Details
(Data available from 10/24/2014 forward)


Earnings History for Tesaro (NASDAQ:TSRO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2016Q2($1.71)($1.28)$4.98 million$36.60 millionViewN/AView Earnings Details
5/5/2016Q1($1.69)($2.22)$2.48 million$0.31 millionViewN/AView Earnings Details
2/25/2016Q4($1.63)($1.89)$3.45 million$0.23 millionViewListenView Earnings Details
10/29/2015Q315($1.52)($1.66)ViewListenView Earnings Details
8/6/2015Q215($1.14)($1.51)ViewListenView Earnings Details
4/30/2015Q115($1.12)($1.30)ViewListenView Earnings Details
2/19/2015Q414($1.03)($1.33)ViewListenView Earnings Details
11/5/2014Q314($1.04)($1.01)ViewN/AView Earnings Details
7/24/2014Q214($0.87)($1.03)ViewN/AView Earnings Details
4/30/2014Q114($1.06)($1.43)ViewN/AView Earnings Details
2/19/2014Q413($0.78)($0.72)ViewN/AView Earnings Details
11/7/2013Q313($0.69)($0.88)ViewN/AView Earnings Details
7/25/2013Q2 2013($0.63)($0.67)ViewN/AView Earnings Details
4/25/2013Q1 2013($0.62)($0.66)ViewN/AView Earnings Details
2/14/2013Q4 2012($0.65)($15.41)ViewN/AView Earnings Details
10/25/2012($0.55)($0.52)ViewN/AView Earnings Details
7/26/2012($0.55)($4.11)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Tesaro (NASDAQ:TSRO)
Current Year EPS Consensus Estimate: $-7.36 EPS
Next Year EPS Consensus Estimate: $-6.11 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($1.69)($1.59)($1.64)
Q2 20162($1.69)($1.58)($1.64)
Q3 20165($1.97)($1.49)($1.72)
Q4 20165($2.01)($1.54)($1.74)
Q1 20171($2.00)($2.00)($2.00)
Q2 20171($1.97)($1.97)($1.97)
Q3 20171($2.23)($2.23)($2.23)
Q4 20171($1.57)($1.57)($1.57)
(Data provided by Zacks Investment Research)


Dividend History for Tesaro (NASDAQ:TSRO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Tesaro (NASDAQ:TSRO)
Insider Ownership Percentage: 40.50%
Institutional Ownership Percentage: 88.88%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/22/2016Martin H Jr. HuberSVPSell408$108.12$44,112.96View SEC Filing  
9/8/2016Edward C EnglishVPSell7,000$88.54$619,780.00View SEC Filing  
8/30/2016Jeffrey H HankeVPSell29,166$86.04$2,509,442.64View SEC Filing  
6/30/2016Jeffrey H HankeVPSell12,500$74.35$929,375.00View SEC Filing  
6/10/2016Edward C EnglishVPSell7,000$40.75$285,250.00View SEC Filing  
3/18/2016Arnold L OronskyDirectorBuy142,085$35.19$4,999,971.15View SEC Filing  
3/18/2016Enterprise Associates 13 L NewMajor ShareholderBuy710,429$35.19$24,999,996.51View SEC Filing  
3/10/2016Edward C EnglishVPSell7,000$43.71$305,970.00View SEC Filing  
12/10/2015Edward C. EnglishVPSell17,000$50.19$853,230.00View SEC Filing  
9/8/2015James O ArmitageDirectorBuy500$54.63$27,315.00View SEC Filing  
12/12/2014James O ArmitageDirectorBuy1,000$38.16$38,160.00View SEC Filing  
9/29/2014Lawrence M AllevaDirectorBuy1,100$26.17$28,787.00View SEC Filing  
7/31/2013Lawrence M AllevaDirectorBuy1,449$34.33$49,744.17View SEC Filing  
6/5/2013Peter J BarrisMajor ShareholderSell3,583$39.00$139,737.00View SEC Filing  
4/30/2013Lawrence M AllevaDirectorBuy1,050$28.10$29,505.00View SEC Filing  
11/1/2012Lawrence M AllevaDirectorBuy3,240$15.45$50,058.00View SEC Filing  
8/30/2012Leon O Moulder JrCEOBuy10,000$11.69$116,900.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Tesaro (NASDAQ:TSRO)
publicnow.com logoTESARO Announces Participation in Three Investor Conferences (NASDAQ:TSRO)
www.publicnow.com - October 24 at 7:28 PM
nasdaq.com logoCommit To Buy Tesaro At $70, Earn 9.9% Using Options (NASDAQ:TSRO)
www.nasdaq.com - October 20 at 8:04 PM
publicnow.com logoTesaro to Announce Third-Quarter 2016 Financial Results on November 3, 2016 (NASDAQ:TSRO)
www.publicnow.com - October 20 at 8:04 PM
News IconTesaro Inc. (TSRO) to Post FY2016 Earnings of ($7.09) Per Share, SunTrust Banks Forecasts - DailyQuint (NASDAQ:TSRO)
dailyquint.com - October 19 at 7:25 PM
News IconA Screaming Buy? Analyst's Take on Tesaro, Inc. (NASDAQ:TSRO) - Recall News (NASDAQ:TSRO)
www.automobile-recalls.net - October 17 at 7:40 PM
News IconInsiders are Scaling Back Holdings in Tesaro, Inc. (NASDAQ:TSRO) - CSZ News (NASDAQ:TSRO)
cincysportszone.com - October 17 at 7:40 PM
investopedia.com logoTesoro Soars on Positive Cancer Drug Results (TSRO) (NASDAQ:TSRO)
www.investopedia.com - October 12 at 10:57 AM
marketexclusive.com logoTESARO Inc (NASDAQ:TSRO): Here’s Our Take On The Data (NASDAQ:TSRO)
marketexclusive.com - October 12 at 10:57 AM
thecountrycaller.com logoTESARO Inc (TSRO) Shares Flying High, Price Target Increased to $128: RBC (NASDAQ:TSRO)
www.thecountrycaller.com - October 12 at 10:57 AM
finance.yahoo.com logoBiotech Stock Roundup: Alnylam Slumps on Revusiran Update, TESARO Impresses at ESMO (NASDAQ:TSRO)
finance.yahoo.com - October 12 at 10:57 AM
News IconEarnings Reaction History: Tesaro, Inc. (NASDAQ:TSRO) has a 50% chance to rise - The Independent Republic (NASDAQ:TSRO)
theindependentrepublic.com - October 11 at 5:59 PM
News IconBiotech Stocks To Put On Your Watch List: Tesaro, Inc. (NASDAQ:TSRO), Celgene Corporation (NASDAQ:CELG) - The Voice Registrar (NASDAQ:TSRO)
voiceregistrar.com - October 11 at 5:59 PM
fool.com logoTesaro Inc. Is Flying High Today (and Could Go Higher From Here) - Motley Fool (NASDAQ:TSRO)
www.fool.com - October 11 at 5:59 PM
streetinsider.com logoUnusual 11 Mid-Day Movers 10/10: (EGAS) (MCUR) (TSRO) Higher; (TWTR) (TWLO) (MYGN) Lower - StreetInsider.com (NASDAQ:TSRO)
www.streetinsider.com - October 11 at 9:29 AM
News IconBiotech Stocks Worth Chasing: ImmunoCellular Therapeutics, Ltd. (IMUC), Tesaro, Inc. (TSRO) - The Independent Republic (NASDAQ:TSRO)
theindependentrepublic.com - October 11 at 9:29 AM
News IconTESARO Inc (NASDAQ:TSRO) Shoots Higher on Results from Ovarian Cancer Drug - Scibility Media (NASDAQ:TSRO)
scibilitymedia.com - October 11 at 9:29 AM
schaeffersresearch.com logoAnalyst Upgrades: Deere & Company, Panera Bread Co, and ... - Schaeffers Research (blog) (NASDAQ:TSRO)
www.schaeffersresearch.com - October 10 at 7:15 PM
investorplace.com logoTesaro Inc (TSRO) Soars on Trial Data, Analyst Upgrades - Investorplace.com (NASDAQ:TSRO)
investorplace.com - October 10 at 7:15 PM
fool.com logoWhat Happened in the Stock Market Today (NASDAQ:TSRO)
www.fool.com - October 10 at 5:35 PM
investorplace.com logoWhy Alphabet Inc (GOOG), Mylan NV (MYL) And Tesaro Inc (TSRO) Are 3 of Today’s Best Stocks (NASDAQ:TSRO)
investorplace.com - October 10 at 5:12 PM
News IconAnalysts Chase Tesaro Targets and Ratings Higher (NASDAQ:TSRO)
feedproxy.google.com - October 10 at 1:25 PM
fool.com logoTesaro Inc. Is Flying High Today (and Could Go Higher From Here) (NASDAQ:TSRO)
www.fool.com - October 10 at 1:06 PM
investorplace.com logoTesaro Inc (TSRO) Soars on Trial Data, Analyst Upgrades (NASDAQ:TSRO)
investorplace.com - October 10 at 11:15 AM
feeds.benzinga.com logo16 Stocks Moving In Monday's Pre-Market Session (NASDAQ:TSRO)
feeds.benzinga.com - October 10 at 9:12 AM
4-traders.com logoTESARO : and ENGOT Announce Presentation of Successful Niraparib Phase 3 ENGOT-OV16/NOVA Trial Results During ESMO 2016 (NASDAQ:TSRO)
www.4-traders.com - October 10 at 8:48 AM
streetinsider.com logoTESARO (TSRO) Presents Statistically Significant Phase 3 ENGOT-OV16/NOVA Trial Results at ESMO (NASDAQ:TSRO)
www.streetinsider.com - October 10 at 8:48 AM
finance.yahoo.com logo3:01 am Tesaro and ENGOT present successful Niraparib Phase 3 results of ENGOT-OV16/NOVA trial (NASDAQ:TSRO)
finance.yahoo.com - October 10 at 8:48 AM
bizjournals.com logo​Analysts hike outlook for Waltham’s Tesaro after ovarian cancer drug data (NASDAQ:TSRO)
www.bizjournals.com - October 10 at 8:48 AM
realistinvestor.com logoTESARO, Inc. (NASDAQ:TSRO) Mean Price Target At $104.8 - RealistInvestor.com (NASDAQ:TSRO)
www.realistinvestor.com - October 9 at 9:10 AM
ft.com logoTESARO Inc (NASDAQ:TSRO)
markets.ft.com - October 8 at 8:32 AM
streetinsider.com logoTESARO and ENGOT Announce Presentation of Successful Niraparib Phase 3 ENGOT-OV16/NOVA Trial Results During ESMO 2016 (NASDAQ:TSRO)
www.streetinsider.com - October 8 at 8:32 AM
feeds.reuters.com logoUPDATE 1-Tesaro's ovarian cancer drug benefits all patients in study (NASDAQ:TSRO)
feeds.reuters.com - October 8 at 5:10 AM
feeds.reuters.com logoTesaro ovarian cancer drug shows broad benefits in study (NASDAQ:TSRO)
feeds.reuters.com - October 8 at 3:48 AM
News IconBiotech Stocks Technical Reports -- Tesaro, CTI BioPharma, Sage Therapeutics, and Lexicon Pharma (NASDAQ:TSRO)
www.kswo.com - October 7 at 9:12 AM
News IconScorching Hot Biotech Stocks Tape: TESARO, Inc. (TSRO), Incyte Corporation (INCY) - The Independent Republic (NASDAQ:TSRO)
theindependentrepublic.com - October 5 at 7:37 PM
News IconTESARO Inc's Trend Up, Especially After This Options Activity - Frisco Fastball (NASDAQ:TSRO)
friscofastball.com - October 5 at 9:02 AM
News IconPay Close Attention To These Analyst Ratings TESARO Inc (NASDAQ:TSRO), Crown Holdings, Inc. (NYSE:CCK) - The Voice Registrar (NASDAQ:TSRO)
voiceregistrar.com - October 5 at 9:02 AM
News IconConsensus Analyst Opinions for: TESARO, Inc. (NASDAQ:TSRO ... - Wall Street Times (press release) (NASDAQ:TSRO)
www.wallstreetnews24.com - October 3 at 7:14 PM
News IconWorth Watching Stock: TESARO, Inc. (NASDAQ:TSRO), Hertz Global Holdings, Inc (NYSE:HTZ) - Newburgh Press (NASDAQ:TSRO)
newburghpress.com - October 2 at 8:55 AM
forbes.com logoNoteworthy Thursday Option Activity: DVN, WFC, TSRO (NASDAQ:TSRO)
www.forbes.com - September 30 at 7:03 PM
streetinsider.com logoTESARO (TSRO) Announces Collaboration with China's Zai Lab - StreetInsider.com (NASDAQ:TSRO)
www.streetinsider.com - September 30 at 9:03 AM
News IconTESARO, Inc. (NASDAQ:TSRO) Updated Broker Price Targets - The De Soto Edge (NASDAQ:TSRO)
desotoedge.com - September 29 at 7:42 PM
globenewswire.com logoTESARO and Zai Lab Announce Collaboration, Development and ... - GlobeNewswire (press release) (NASDAQ:TSRO)
globenewswire.com - September 29 at 7:42 PM
News IconAnalysts Valuations For Two Stocks: Brunswick Corporation (NYSE:BC), TESARO Inc (NASDAQ:TSRO) - The Voice Registrar (NASDAQ:TSRO)
voiceregistrar.com - September 29 at 7:42 PM
publicnow.com logoTESARO and Zai Lab Announce Collaboration, Development and License Agreement (NASDAQ:TSRO)
www.publicnow.com - September 29 at 8:59 AM
biz.yahoo.com logoTESARO, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Stat (NASDAQ:TSRO)
biz.yahoo.com - September 29 at 8:59 AM
feeds.reuters.com logoBRIEF-Tesaro and Zai Lab announce collaboration, development and license agreement (NASDAQ:TSRO)
feeds.reuters.com - September 29 at 7:36 AM
4-traders.com logoTESARO : Announces Participation at Four Investor Conferences (NASDAQ:TSRO)
www.4-traders.com - September 24 at 6:56 PM
News IconEarnings Preview: Tesaro, Inc. (NASDAQ:TSRO) moved down 8 times out of last 15 quarters - The Independent Republic (NASDAQ:TSRO)
theindependentrepublic.com - September 22 at 7:26 PM
News IconActive biotech company shares in the news: Tesaro, Inc. (NASDAQ:TSRO), Ultragenyx Pharmaceutical Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:TSRO)
voiceregistrar.com - September 21 at 7:17 PM


Tesaro (NASDAQ:TSRO) Chart for Monday, October, 24, 2016

Last Updated on 10/24/2016 by MarketBeat.com Staff